Skip to main content
Top
Published in: BMC Gastroenterology 1/2019

Open Access 01-12-2019 | Hepatocellular Carcinoma | Case report

Three cases of histologically proven hepatic epithelioid hemangioendothelioma evaluated using a second-generation microbubble contrast medium in ultrasonography: case reports

Authors: Jun Arai, Yuu Shimozuma, Yumi Otoyama, Ikuya Sugiura, Yoko Nakajima, Eiichi Hayashi, Atsushi Kajiwara, Risa Omori, Shojiro Uozumi, Miyuki Miyashita, Manabu Uchikoshi, Hiroyoshi Doi, Masashi Sakaki, Tianpeng Wang, Junichi Eguchi, Takayoshi Ito, Toshikazu Kurihara, Jiro Munechika, Takehiko Gokan, Koji Saito, Sakiko Miura, Genshu Tate, Masafumi Takimoto, Hitoshi Yoshida

Published in: BMC Gastroenterology | Issue 1/2019

Login to get access

Abstract

Background

Hepatic epithelioid hemangioendothelioma (HEH) is rare; it is reported in < 1 person in 1,000,000 individuals. For accurate diagnosis, information regarding multiple graphic modalities in HEH is required. However, there is very little information concerning Sonazoid® contrast enhanced ultrasonography (CEUS) in HEH.

Case presentation

The present report describes the histologically proven three HEH cases evaluated using Sonazoid® CEUS. Case 1 was a 33-year-old female patient with no relevant past medical history, who experienced right upper quadrant pain. Conventional abdominal US revealed multiple low echoic liver nodules with vague borderlines. In CEUS, the vascularity of the nodules was similar to that seen in the neighboring normal liver. Later in the portal venous and late phases (PVLP) and post vascular phase, washout of Sonazoid® was detected in the nodules. Case 2 was a 93-year-old female patient with a previous medical history including operations for breast cancer and ovary cancer in her 50’s. Conventional abdominal US revealed multiple low echoic nodules, some of which contained cystic lesions. In the early vascular phase of CEUS, nodules excluding the central anechoic regions were enhanced from peripheral sites. Although the enhancement inside the nodules persisted in both the PVLP and post vascular phase, anechoic areas in the center of some nodules were not enhanced at all. Case 3 was a 39-year-old male patient presented with right upper-quadrant pain, without any relevant past medical history. Conventional abdominal US revealed multiple low echoic liver nodules. In the early vascular phase of CEUS, nodules were gradually enhanced from the peripheral sites as ringed enhancement. Sonazoid®was washed out from the nodules in the PVLP and post vascular phase.

Conclusions

The most important feature was peripheral enhancement in the early vascular phase. In case 2, the enhancement of the parenchyma of liver nodules persisted even in the PVLP; indicating the lower degree of malignant potential than others. Actually, the tumors did not extend without any treatment in case 2. Since case 2 is the first case report of HEH with cystic lesions, in patients with liver nodules including cystic lesions, HEH is a potential diagnosis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Mehrabi A, Kashfi A, Fonouni H, et al. Primary malignant hepatic epithelioid hemangioendothelioma: a comprehensive review of the literature with emphasis on the surgical therapy. Cancer. 2006;107:2108–21.CrossRef Mehrabi A, Kashfi A, Fonouni H, et al. Primary malignant hepatic epithelioid hemangioendothelioma: a comprehensive review of the literature with emphasis on the surgical therapy. Cancer. 2006;107:2108–21.CrossRef
2.
go back to reference Nakatani Y, Aoki I, Nisugi K, et al. Immunohistochemical and ultrastructural study of early lesions of intravascular bronchioloalveolar tumor with liver involvement. Acta Pathol Jpn. 1985;35:1453–65.PubMed Nakatani Y, Aoki I, Nisugi K, et al. Immunohistochemical and ultrastructural study of early lesions of intravascular bronchioloalveolar tumor with liver involvement. Acta Pathol Jpn. 1985;35:1453–65.PubMed
3.
go back to reference Mori R, Miura M, Takahashi T, et al. A Case of Epithelioid Hemangioendothelioma of the Liver with Difficulty in Preoperative Diagnosis. Jpn J Gastroenterol Surg. 2004;37:539–44 (abstract in English).CrossRef Mori R, Miura M, Takahashi T, et al. A Case of Epithelioid Hemangioendothelioma of the Liver with Difficulty in Preoperative Diagnosis. Jpn J Gastroenterol Surg. 2004;37:539–44 (abstract in English).CrossRef
4.
go back to reference Earnest F 4th, Johnson CD. Case 96: hepatic Epithelioid hemangioendothelioma. Radiology. 2006;240:295–8.CrossRef Earnest F 4th, Johnson CD. Case 96: hepatic Epithelioid hemangioendothelioma. Radiology. 2006;240:295–8.CrossRef
5.
go back to reference Kim EH, Rha SE, Lee YJ, et al. CT and MR imaging findings of hepatic epithelioid hemangioendotheliomas: emphasis on single nodular type. Abdom Imaging. 2015;40:500–9.CrossRef Kim EH, Rha SE, Lee YJ, et al. CT and MR imaging findings of hepatic epithelioid hemangioendotheliomas: emphasis on single nodular type. Abdom Imaging. 2015;40:500–9.CrossRef
6.
go back to reference Moriyasu F, Itoh K. Efficacy of perflubutane microbubble-enhanced ultrasound in the characterization and detection of focal liver lesions: phase 3 multicenter clinical trial. AJR Am J Roentgenol. 2009;193:86–95.CrossRef Moriyasu F, Itoh K. Efficacy of perflubutane microbubble-enhanced ultrasound in the characterization and detection of focal liver lesions: phase 3 multicenter clinical trial. AJR Am J Roentgenol. 2009;193:86–95.CrossRef
7.
go back to reference Kudo M. Diagnostic imaging of hepatocellular carcinoma: recent progress. Oncology. 2011;81:73–85.CrossRef Kudo M. Diagnostic imaging of hepatocellular carcinoma: recent progress. Oncology. 2011;81:73–85.CrossRef
8.
go back to reference Kudo M. The 2008 Okuda lecture: management of hepatocellular carcinoma: from surveillance to molecular targeted therapy. J Gastroenterol Hepatol. 2010;25:439–52.CrossRef Kudo M. The 2008 Okuda lecture: management of hepatocellular carcinoma: from surveillance to molecular targeted therapy. J Gastroenterol Hepatol. 2010;25:439–52.CrossRef
9.
go back to reference Alaboudy A, Inoue T, Hatanaka K, et al. Usefulness of combination of imaging modalities in the diagnosis of hepatocellular carcinoma using Sonazoid®-enhanced ultrasound, gadolinium diethylene-triamine-pentaacetic acid-enhanced magnetic resonance imaging, and contrast-enhanced computed tomography. Oncology. 2011;81:66–72.CrossRef Alaboudy A, Inoue T, Hatanaka K, et al. Usefulness of combination of imaging modalities in the diagnosis of hepatocellular carcinoma using Sonazoid®-enhanced ultrasound, gadolinium diethylene-triamine-pentaacetic acid-enhanced magnetic resonance imaging, and contrast-enhanced computed tomography. Oncology. 2011;81:66–72.CrossRef
10.
go back to reference Hayashi H, Nishigaki Y, Tomita E, et al. Usefulness of early vascular phase images from contrast-enhanced ultrasonography using Sonazoid for the diagnosis of hypovascular hepatocellular carcinoma. Hepatol Res. 2016;46:497–504.CrossRef Hayashi H, Nishigaki Y, Tomita E, et al. Usefulness of early vascular phase images from contrast-enhanced ultrasonography using Sonazoid for the diagnosis of hypovascular hepatocellular carcinoma. Hepatol Res. 2016;46:497–504.CrossRef
11.
go back to reference Weiss SW, Enzinger FM. Epithelioid hemangioendothelioma, avascular tumor often mistaken for a carcinoma. Cancer. 1982;50:970–81.CrossRef Weiss SW, Enzinger FM. Epithelioid hemangioendothelioma, avascular tumor often mistaken for a carcinoma. Cancer. 1982;50:970–81.CrossRef
12.
go back to reference Makhlouf HR, Ishak KG, Goodman ZD, et al. Epithelioid hemangioendothelioma of the liver: a clinicopathologic study of 137cases. Cancer. 1999;85:562–82.CrossRef Makhlouf HR, Ishak KG, Goodman ZD, et al. Epithelioid hemangioendothelioma of the liver: a clinicopathologic study of 137cases. Cancer. 1999;85:562–82.CrossRef
13.
go back to reference Dong Y, Wang W-P, Cantisani V, et al. Contrast-enhanced ultrasound of histologically proven hepatic epithelioid hemangioendothelioma. World J Gastroenterol. 2016;22:4741–9.CrossRef Dong Y, Wang W-P, Cantisani V, et al. Contrast-enhanced ultrasound of histologically proven hepatic epithelioid hemangioendothelioma. World J Gastroenterol. 2016;22:4741–9.CrossRef
14.
go back to reference Miller WJ, Dodd GD 3rd, Federle MP, et al. Epithelioid hemangioendothelioma of the liver: imaging findings with pathologic correlation. AJR Am J Roentgenol. 1992;59:53–7.CrossRef Miller WJ, Dodd GD 3rd, Federle MP, et al. Epithelioid hemangioendothelioma of the liver: imaging findings with pathologic correlation. AJR Am J Roentgenol. 1992;59:53–7.CrossRef
15.
go back to reference Van Beers B, Roche A, Mathieu D, et al. Epithelioid hemangioendothelioma of the liver: MR and CT findings. J Comput Assist Tomogr. 1992;16:420–4.CrossRef Van Beers B, Roche A, Mathieu D, et al. Epithelioid hemangioendothelioma of the liver: MR and CT findings. J Comput Assist Tomogr. 1992;16:420–4.CrossRef
16.
go back to reference Dietrich CF, Mertens JC, Braden B, et al. Contrast-enhanced ultrasound of histologically proven liver Hemangiomas. Hepatology. 2007;45:1139–45.CrossRef Dietrich CF, Mertens JC, Braden B, et al. Contrast-enhanced ultrasound of histologically proven liver Hemangiomas. Hepatology. 2007;45:1139–45.CrossRef
17.
go back to reference von Herbay A, Vogt C, Haussinger D, et al. Late-phase pulse-inversion sonography using the contrast agent levovist: differentiation between benign and malignant focal lesions of the liver. AJR Am J Roentgenol. 2002;179:1273–9.CrossRef von Herbay A, Vogt C, Haussinger D, et al. Late-phase pulse-inversion sonography using the contrast agent levovist: differentiation between benign and malignant focal lesions of the liver. AJR Am J Roentgenol. 2002;179:1273–9.CrossRef
18.
go back to reference Dietrich CF, Ignee A, Trojan J, et al. Improved characterisation of histologically proven liver tumours by contrast enhanced ultrasonography during the portal venous and specific late phase of SHU508A. Gut. 2004;53:401–5.CrossRef Dietrich CF, Ignee A, Trojan J, et al. Improved characterisation of histologically proven liver tumours by contrast enhanced ultrasonography during the portal venous and specific late phase of SHU508A. Gut. 2004;53:401–5.CrossRef
Metadata
Title
Three cases of histologically proven hepatic epithelioid hemangioendothelioma evaluated using a second-generation microbubble contrast medium in ultrasonography: case reports
Authors
Jun Arai
Yuu Shimozuma
Yumi Otoyama
Ikuya Sugiura
Yoko Nakajima
Eiichi Hayashi
Atsushi Kajiwara
Risa Omori
Shojiro Uozumi
Miyuki Miyashita
Manabu Uchikoshi
Hiroyoshi Doi
Masashi Sakaki
Tianpeng Wang
Junichi Eguchi
Takayoshi Ito
Toshikazu Kurihara
Jiro Munechika
Takehiko Gokan
Koji Saito
Sakiko Miura
Genshu Tate
Masafumi Takimoto
Hitoshi Yoshida
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2019
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-019-1113-y

Other articles of this Issue 1/2019

BMC Gastroenterology 1/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.